Mark Strobeck
Chief Executive Officer chez ROCKWELL MEDICAL, INC.
Fortune : 35 909 $ au 31/03/2024
Profil
Mark Strobeck currently works at Rockwell Medical, Inc., as President, Chief Executive Officer & Director from 2022, Windtree Therapeutics, Inc., as Independent Director from 2023, and Horse Power For Life, as Director from 2012.
Dr. Strobeck also formerly worked at Corridor Pharmaceuticals, Inc., as President & Chief Executive Officer from 2012 to 2013, Novalar Pharmaceuticals, Inc., as Director, Aquilo Partners LP, as Managing Director from 2021 to 2022, Protein Forest, Inc., as Director, Assertio Therapeutics, Inc., as Chief Operating Officer & Executive Vice President in 2020, Standard BioTools, Inc., as Board Observer, Santarus, Inc., as Board Observer, Topaz Pharmaceuticals, Inc., as Chief Business Officer & Vice President from 2010 to 2011, Zyla Life Sciences LLC, as Chief Operating Officer & Executive Vice President from 2015 to 2020, GSK Equity Investments Ltd., as Principal from 2004 to 2006, Mitsubishi Tanabe Pharma Corp., as Principal, KuDOS Pharmaceuticals Ltd., as Board Observer, GlaxoSmithKline, Inc., as Vice President-Business Development from 2003 to 2008, Ben Franklin Technology Partners, as Member, Trevena, Inc., as Chief Business Officer from 2008 to 2010, and Assertio Holdings, Inc., as Chief Operating Officer & Executive Vice President in 2020.
Dr. Strobeck received his doctorate degree in 1999 from the University of Cincinnati (Ohio) and undergraduate degree in 1993 from St. Lawrence University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ROCKWELL MEDICAL, INC.
0,07% | 25/03/2024 | 21 632 ( 0,07% ) | 35 909 $ | 31/03/2024 |
Postes actifs de Mark Strobeck
| Sociétés | Poste | Début |
|---|---|---|
| ROCKWELL MEDICAL, INC. | Chief Executive Officer | 01/07/2022 |
| WINDTREE THERAPEUTICS, INC. | Director/Board Member | 22/06/2023 |
| Horse Power For Life | Director/Board Member | 01/01/2012 |
Anciens postes connus de Mark Strobeck
| Sociétés | Poste | Fin |
|---|---|---|
Aquilo Partners LP
 Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Corporate Officer/Principal | 01/06/2022 |
| ASSERTIO HOLDINGS, INC. | Chief Operating Officer | 14/12/2020 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Chief Operating Officer | 14/12/2020 |
| ZYLA LIFE SCIENCES | Chief Operating Officer | 20/05/2020 |
Corridor Pharmaceuticals, Inc.
 Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Chief Executive Officer | 01/12/2013 |
Formation de Mark Strobeck
| University of Cincinnati (Ohio) | Doctorate Degree |
| St. Lawrence University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| ROCKWELL MEDICAL, INC. | Health Technology |
| STANDARD BIOTOOLS INC. | Health Technology |
| TREVENA, INC. | Health Technology |
| ASSERTIO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 14 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
Novalar Pharmaceuticals, Inc.
 Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Aquilo Partners LP
Aquilo Partners LP Investment ManagersFinance Aquilo Partners LP provides corporate finance, mergers & acquisitions and strategic advisory services to public and private life science companies. It also provides buyside M&A, sellside M&A, partnering and private placement. The company was founded by Brian Polzak, John Rumsey and James Zanze in 2001 and is located in San Francisco, CA. | Finance |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
KuDOS Pharmaceuticals Ltd.
 KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK. | Health Technology |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Protein Forest, Inc.
 Protein Forest, Inc. Packaged SoftwareTechnology Services Protein Forest, Inc., a privately held company founded in 2002 and is located in Lexington, MA, is a developer and manufacturer of state-of-the-art sample fractionation technology, products, and data analysis software for mass spectrometry. The company develops, manufactures, and markets instruments, consumables, and bioinformatics software products for scientists in the life science, drug discovery, pharmaceutical, biotech, and diagnostic industries around the world. | Technology Services |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Corridor Pharmaceuticals, Inc.
Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Health Technology |
| Horse Power For Life |
